Indian court provokes storm over drugs patent linkage
19 January 2009
Peter Ollier, Hong Kong
Two patent disputes before the Delhi High Court have raised the issue of patent linkage between the India Patent Office and the Office of the Drug Controller General of India (DCGI)
The disputes threaten to require the Drug Controller to consider whether generic drugs infringe patents before it issues marketing approval.
In one case, which was argued today, German pharmaceutical company...
Only subscribers have complete access to Managing IP Magazine,
log in or
subscribe now.
Alternatively take a
free trial, giving you 48-hour access to Managing IP Magazine (some articles and surveys may be excluded).
Subscribe Now
This article is available to subscribers. Please click subscribe to read the rest of the article.
Subscribe
Take a free trial
Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.
Take a free trial